Re-biopsy and liquid biopsy for patients with non-small cell lung cancer after EGFR-tyrosine kinase inhibitor failure.

Juan ZhouChao ZhaoJing ZhaoQi WangXiangling ChuJiayu LiFei ZhouShengxiang RenXuefei LiChunxia SuCaicun Zhou

Published in: Thoracic cancer (2019)

Re-biopsy plays a pivotal role in the management of patients with NSCLC and resistance to EGFR-TKIs. Liquid biopsy may be an alternative if difficulties performing re-biopsy exist.

Keyphrases

ultrasound guided
small cell lung cancer
fine needle aspiration
epidermal growth factor receptor
tyrosine kinase
ionic liquid
advanced non small cell lung cancer